イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - entacapone 200 mg - film coated tablets - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - clozapine 25 mg - tablets - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death.

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - imipramine hydrochloride 25 mg - tablets - imipramine - treatment of various types of depression. in children and adolescents there is not sufficient evidence of safety and efficacy of tofranil in the treatment of all forms of depression. the use of tofranil in children and adolescents ( 0 - 17 years of age) in these indications is therefore not recommended.

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - methylphenidate hydrochloride 30 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - methylphenidate hydrochloride 20 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - methylphenidate hydrochloride 10 mg - modified release capsules - methylphenidate - attention deficit hyperactivity disorder (adhd) .

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - rivastigmine 4.6 mg/day - patches - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - rivastigmine 9.5 mg/day - patches - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.

イスラエル - ヘブライ語 - Ministry of Health

novartis pharma services ag - indacaterol as maleate 300 mcg - inhalation powder hard capsules - indacaterol - maintenance of bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (copd).